Bingfeng Shao

High expression of TOP2A in hepatocellular carcinoma is associated with disease progression and poor prognosis

Hongyu Cai, Bingfeng Shao, Yuan Zhou et al. · Oncology Letters · 2020 · 47 citations · Full text

Medicine, Cancer Biology, Oncology +17

Toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma (HEPATORCH): a randomised, open-label, phase 3 trial

Ying–Hong Shi, Guohong Han, Jian Zhou et al. · ˜The œLancet. Gastroenterology & hepatology · 2025 · 39 citations

Medicine, Oncology, Pharmacology +10

Expression of leucine aminopeptidase 3 (LAP3) correlates with prognosis and malignant development of human hepatocellular carcinoma (HCC).

Siyuan Tian, Shou-Hua Chen, Bingfeng Shao et al. · PubMed · 2014 · 32 citations

Medicine, Cancer Biology, Oncology +17

High expression of TOP2A gene predicted poor prognosis of hepatocellular carcinoma after radical hepatectomy

Hongyu Cai, Xinhua Zhu, Fei Qian et al. · Translational Cancer Research · 2020 · 21 citations · Full text

Medicine, Molecular Biology, Oncology +17

Glycolysis-related gene dihydrolipoamide acetyltransferase promotes poor prognosis in hepatocellular carcinoma through the Wnt/β-catenin and PI3K/Akt signaling pathways

Yuan Zhou, Haijuan Gu, Bingfeng Shao et al. · Annals of Translational Medicine · 2022 · 17 citations · Full text

Medicine, Cancer Biology, Oncology +17